rs34767818

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001723.7(DST):ā€‹c.3336G>Cā€‹(p.Glu1112Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00492 in 1,613,844 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0034 ( 1 hom., cov: 32)
Exomes š‘“: 0.0051 ( 26 hom. )

Consequence

DST
NM_001723.7 missense

Scores

5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:3

Conservation

PhyloP100: 0.498
Variant links:
Genes affected
DST (HGNC:1090): (dystonin) This gene encodes a member of the plakin protein family of adhesion junction plaque proteins. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the full-length nature of some variants has not been defined. It has been reported that some isoforms are expressed in neural and muscle tissue, anchoring neural intermediate filaments to the actin cytoskeleton, and some isoforms are expressed in epithelial tissue, anchoring keratin-containing intermediate filaments to hemidesmosomes. Consistent with the expression, mice defective for this gene show skin blistering and neurodegeneration. [provided by RefSeq, Mar 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006155789).
BP6
Variant 6-56620698-C-G is Benign according to our data. Variant chr6-56620698-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 357589.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=4}. Variant chr6-56620698-C-G is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DSTNM_001723.7 linkuse as main transcriptc.3336G>C p.Glu1112Asp missense_variant 23/24 ENST00000370765.11 NP_001714.1
DSTNM_001374736.1 linkuse as main transcriptc.4929+3832G>C intron_variant ENST00000680361.1 NP_001361665.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DSTENST00000370765.11 linkuse as main transcriptc.3336G>C p.Glu1112Asp missense_variant 23/241 NM_001723.7 ENSP00000359801 Q03001-3
DSTENST00000680361.1 linkuse as main transcriptc.4929+3832G>C intron_variant NM_001374736.1 ENSP00000505098

Frequencies

GnomAD3 genomes
AF:
0.00338
AC:
514
AN:
152168
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00106
Gnomad AMI
AF:
0.00439
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00564
Gnomad OTH
AF:
0.00431
GnomAD3 exomes
AF:
0.00347
AC:
868
AN:
250036
Hom.:
1
AF XY:
0.00354
AC XY:
478
AN XY:
135212
show subpopulations
Gnomad AFR exome
AF:
0.00124
Gnomad AMR exome
AF:
0.00188
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00170
Gnomad FIN exome
AF:
0.000555
Gnomad NFE exome
AF:
0.00607
Gnomad OTH exome
AF:
0.00360
GnomAD4 exome
AF:
0.00508
AC:
7428
AN:
1461558
Hom.:
26
Cov.:
33
AF XY:
0.00498
AC XY:
3619
AN XY:
727106
show subpopulations
Gnomad4 AFR exome
AF:
0.00105
Gnomad4 AMR exome
AF:
0.00197
Gnomad4 ASJ exome
AF:
0.00149
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00170
Gnomad4 FIN exome
AF:
0.000713
Gnomad4 NFE exome
AF:
0.00612
Gnomad4 OTH exome
AF:
0.00439
GnomAD4 genome
AF:
0.00338
AC:
515
AN:
152286
Hom.:
1
Cov.:
32
AF XY:
0.00273
AC XY:
203
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.00106
Gnomad4 AMR
AF:
0.00360
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.000565
Gnomad4 NFE
AF:
0.00564
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.00519
Hom.:
2
Bravo
AF:
0.00381
TwinsUK
AF:
0.00701
AC:
26
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00605
AC:
52
ExAC
AF:
0.00325
AC:
395
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00622
EpiControl
AF:
0.00610

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJun 07, 2021In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25790160) -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024DST: BP4, BS2 -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicOct 14, 2019- -
Hereditary sensory and autonomic neuropathy type 6 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium Ii, University Of MiamiJan 06, 2016- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 02, 2022Unlikely to be causative of DST-related sensory and autonomic neuropathy (AR) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
DST-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 12, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
21
DANN
Uncertain
0.99
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.51
T
M_CAP
Benign
0.0046
T
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-1.0
T
PROVEAN
Uncertain
-2.9
D
REVEL
Benign
0.070
Sift
Benign
0.45
T
Sift4G
Uncertain
0.057
T
Polyphen
0.99
D
Vest4
0.50
MutPred
0.17
Loss of methylation at K1108 (P = 0.1648);
MVP
0.38
ClinPred
0.024
T
GERP RS
4.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34767818; hg19: chr6-56485496; COSMIC: COSV55006055; COSMIC: COSV55006055; API